OpenURL Connection Search

Select item for more details and to access through your institution.

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
Published in:
Oncogene, 2013, v. 32, n. 36, p. 4284, doi. 10.1038/onc.2012.433
By:
- van Jaarsveld, M T M;
- Helleman, J;
- Boersma, A W M;
- van Kuijk, P F;
- van IJcken, W F;
- Despierre, E;
- Vergote, I;
- Mathijssen, R H J;
- Berns, E M J J;
- Verweij, J;
- Pothof, J;
- Wiemer, E A C
Publication type:
Article
Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 4, p. 1653, doi. 10.1210/jc.2002-021585
By:
- POWELL, B. L.;
- PIERSMA, D.;
- KEVENAAR, M. E.;
- VAN STAVEREN, I. L.;
- THEMMEN, A. P. N.;
- IACOPETTA, B. J.;
- BERNS, E. M. J. J.
Publication type:
Article
Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 4, p. 1653, doi. 10.1210/jc.2002-021585
By:
- POWELL, B. L.;
- PIERSMA, D.;
- KEVENAAR, M. E.;
- VAN STAVEREN, I. L.;
- THEMMEN, A. P. N.;
- IACOPETTA, B. J.;
- BERNS, E. M. J. J.
Publication type:
Article
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.
Published in:
2009
By:
- Trinh, X. B.;
- Tjalma, W. A. A.;
- Vermeulen, P. B.;
- Van den Eynden, G.;
- Van der Auwera, I.;
- Van Laere, S. J.;
- Helleman, J.;
- Berns, E. M. J. J.;
- Dirix, L. Y.;
- van Dam, P. A.
Publication type:
journal article
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
Published in:
2010
By:
- Burger, H;
- Zoumaro-Djayoon, A;
- Boersma, AWM;
- Helleman, J;
- Berns, EMJJ;
- Mathijssen, RHJ;
- Loos, WJ;
- Wiemer, EAC;
- Boersma, A W M;
- Berns, E M J J;
- Mathijssen, R H J;
- Loos, W J;
- Wiemer, E A C
Publication type:
journal article
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
Published in:
British Journal of Cancer, 2001, v. 85, n. 9, p. 1359, doi. 10.1054/bjoc.2001.2101
By:
- Schuyer, M;
- Burg, M E L van der;
- Henzen-Logmans, S C;
- Fieret, J H;
- Klijn, J G M;
- Look, M P;
- Foekens, J A;
- Stoter, G;
- Berns, E M J J
Publication type:
Article
Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features.
Published in:
British Journal of Cancer, 2001, v. 85, n. 4, p. 538, doi. 10.1054/bjoc.2001.1937
By:
- Berns, E M J J;
- Staveren, I L van;
- Verhoog, L;
- Ouweland, A M W van de;
- Gelder, M Meijer-van;
- Meijers-Heijboer, H;
- Portengen, H;
- Foekens, J A;
- Dorssers, L C J;
- Klijn, J G M
Publication type:
Article

Found: 7

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset.

Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset.

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.

Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features.